Biocryst Pharmaceuticals (BCRX) Share-based Compensation: 2010-2015
Historic Share-based Compensation for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to $1.9 million.
- Biocryst Pharmaceuticals' Share-based Compensation fell 46.73% to $1.9 million in Q4 2015 from the same period last year, while for Dec 2015 it was $9.7 million, marking a year-over-year decrease of 4.64%. This contributed to the annual value of $65.4 million for FY2024, which is 17.62% up from last year.
- As of Q4 2015, Biocryst Pharmaceuticals' Share-based Compensation stood at $1.9 million, which was up 5.06% from $1.8 million recorded in Q3 2015.
- In the past 5 years, Biocryst Pharmaceuticals' Share-based Compensation registered a high of $3.7 million during Q2 2015, and its lowest value of $822,000 during Q4 2012.
- Its 3-year average for Share-based Compensation is $2.0 million, with a median of $1.7 million in 2014.
- In the last 5 years, Biocryst Pharmaceuticals' Share-based Compensation soared by 307.99% in 2014 and then crashed by 46.73% in 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Share-based Compensation (Quarterly) stood at $900,000 in 2011, then decreased by 8.67% to $822,000 in 2012, then rose by 8.15% to $889,000 in 2013, then skyrocketed by 307.99% to $3.6 million in 2014, then tumbled by 46.73% to $1.9 million in 2015.
- Its Share-based Compensation was $1.9 million in Q4 2015, compared to $1.8 million in Q3 2015 and $3.7 million in Q2 2015.